−0.220 HKD
−95.09 M HKD
703.97 M HKD
179.88 M
About CHANGMAO BIOCHEMICAL ENGINEERING
Sector
CEO
Chun Pan
Headquarters
Changzhou
Website
Founded
1992
ISIN
CNE100000106
FIGI
BBG000NDFJM3
Changmao Biochemical Engineering Co., Ltd. engages in the production and trade of organic acids. It offers fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame which are usually used in food additives and medical intermediaries. The company was founded by Xin Sheng Rui on December 3, 1992 and is headquartered in Changzhou, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 954 is 0.400 HKD — it has decreased by −1.23% in the past 24 hours. Watch CHANGMAO BIOCHEMICAL ENGINEERING stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CHANGMAO BIOCHEMICAL ENGINEERING stocks are traded under the ticker 954.
954 stock has fallen by −1.23% compared to the previous week, the month change is a −9.09% fall, over the last year CHANGMAO BIOCHEMICAL ENGINEERING has showed a −29.82% decrease.
954 stock is 0.00% volatile and has beta coefficient of 0.14. Track CHANGMAO BIOCHEMICAL ENGINEERING stock price on the chart and check out the list of the most volatile stocks — is CHANGMAO BIOCHEMICAL ENGINEERING there?
Today CHANGMAO BIOCHEMICAL ENGINEERING has the market capitalization of 214.53 M, it has decreased by −1.22% over the last week.
Yes, you can track CHANGMAO BIOCHEMICAL ENGINEERING financials in yearly and quarterly reports right on TradingView.
954 net income for the last half-year is −20.36 M HKD, while the previous report showed −97.46 M HKD of net income which accounts for 79.11% change. Track more CHANGMAO BIOCHEMICAL ENGINEERING financial stats to get the full picture.
As of Dec 27, 2024, the company has 631.00 employees. See our rating of the largest employees — is CHANGMAO BIOCHEMICAL ENGINEERING on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHANGMAO BIOCHEMICAL ENGINEERING EBITDA is −47.20 M HKD, and current EBITDA margin is 3.39%. See more stats in CHANGMAO BIOCHEMICAL ENGINEERING financial statements.
Like other stocks, 954 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHANGMAO BIOCHEMICAL ENGINEERING stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHANGMAO BIOCHEMICAL ENGINEERING technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHANGMAO BIOCHEMICAL ENGINEERING stock shows the strong sell signal. See more of CHANGMAO BIOCHEMICAL ENGINEERING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.